You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

403 Results
Document
Apr 2022
Document
Apr 2022
Document
Apr 2022
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Drugs Used:
riTUXimab (PDRP prior authorization),
etoposide,
ifosfamide,
mesna,
CARBOplatin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2022
Document
Jul 2022
Document
Aug 2022
Document
Sep 2022
Document
Nov 2022
Document
Nov 2022
Statistical Reports
Cancer facts
Jan 2023
.

Pages